期刊文献+

儿童神经母细胞瘤中ALK基因突变的研究

ALK gene mutations in childhood neuroblastoma
原文传递
导出
摘要 目的探讨中国儿童神经母细胞瘤(NB)中间变性淋巴瘤激酶(ALK)基因的突变情况。方法从22例石蜡包埋的NB肿瘤组织中提取基因组DNA,通过PCR-DNA直接测序技术分析儿童NB肿瘤组织中ALK突变热点区域第20~26号外显子的突变情况。结果 22例儿童NB中,有10例(46%)在ALK第21号外显子上存在已知同义突变C3375A(Gly1125Gly),等位基因频率为27%;1例(5%)在ALK第23号外显子上发现一个新的同义突变C3586T(Leu1196Leu)。ALK突变C3375A的发生频率在NB患儿的年龄、性别、肿瘤分化程度和是否转移方面差异无统计学意义(P>0.05)。在其他5个ALK外显子中未发现突变。结论采用PCR-DNA测序技术发现了ALK一个新的同义突变C3586T,并证实了儿童ALK存在已知突变C3375A,其发生率不受NB患儿临床特征的影响。 Objective To investigate mutations of anaplastic lymphoma kinase(ALK) in Chinese children with neuroblastoma(NB).Methods Genomic DNA was extracted from 22 cases of paraffin-embedding NB tumor tissues.Gene mutations in the exons 20-26 which were mutational hotspots of ALK were analyzed by PCR-DNA direct sequencing.Results A novel synonymous mutation C3586T(Leu1196Leu) and a known synonymous mutation C3375A(Gly1125Gly) were found and located at exon 23 and exon 21 of ALK respectively.There were 10 cases(46%) of known synonymous mutation C3375A in 22 cases of NB.The C3375A allelic frequency was 27%.No statistically significant correlation was found between mutation C3375A and clinical parameters of NB such as age,sex,metastasis and tumor differentiation.Mutation was not found in the other 5 exons.Conclusions A novel ALK gene synonymous mutation C3586T was identified using PCR-DNA sequencing.A known mutation C3375A in ALK was successfully identified in children,and its incidence is not influenced by the clinical features of childhood NB.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2012年第10期763-766,共4页 Chinese Journal of Contemporary Pediatrics
基金 深圳市科技计划项目(编号:201002112)
关键词 神经母细胞瘤 间变性淋巴瘤激酶 基因突变 儿童 Neuroblastoma Anaplastic lymphoma kinase Gene mutation Child
  • 相关文献

参考文献13

  • 1杨春兰,岳丽杰.间变性淋巴瘤激酶与神经母细胞瘤关系的研究进展[J].中国肿瘤临床,2012,29(11):810-812. 被引量:4
  • 2朱琪琦,刘英,冯晨,唐锁勤.神经母细胞瘤远期复发临床研究[J].中国当代儿科杂志,2010,12(12):995-997. 被引量:3
  • 3Azarova AM,Gautam G,George RE.Emerging importance of ALKin neuroblastoma[J].Semin Cancer Biol,2011,21(4):267-275.
  • 4Chen Y,Takita J,Choi YL,Kato M,Ohira M,Sanada M,et al.Oncogenic mutations of ALK kinase in neuroblastoma[J].Nature,2008,455(7215):971-974.
  • 5George RE,Sanda T,Hanna M,Frhling S,Luther W 2nd,Zhang J,et al.Activating mutations in ALK provide a therapeutictarget in neuroblastom[J].Nature,2008,455(7215):975-978.
  • 6Carén H,Abel F,Kogner P,Martinsson T.High incidence ofDNA mutations and gene amplifications of the ALK gene in ad-vanced sporadic neuroblastoma tumors[J].Biochem J,2008,416(2):153-159.
  • 7Li R,Morris SW.Development of anaplastic lymphoma kinase(ALK)small-molecule inhibitors for cancer therapy[J].Med ResRev,2008,28(3):372-412.
  • 8Pearson R,Kolesar JM.Targeted therapy for NSCLC:ALK inhibi-tion[J].J Oncol Pharm Pract,2012,18(2):271-274.
  • 9Janoueix-Lerosey I,Lequin D,Brugières L,Ribeiro A,de Pontu-al L,Combaret V,et al.Somatic and germline activating muta-tions of the ALK kinase receptor in neuroblastoma[J].Nature,2008,455(7215):967-970.
  • 10MosséYP,Laudenslager M,Longo L,Cole KA,Wood A,AttiyehEF,et al.Identification of ALK as a major familial neuroblastomapredisposition gene[J].Nature,2008,455(7215):930-935.

二级参考文献37

  • 1唐锁勤,黄东生,王建文,张晓飞,刘立真,于芳,杨光.强烈化疗和自体外周血造血干细胞移植及维甲酸治疗晚期神经母细胞瘤[J].中华儿科杂志,2004,42(7):486-489. 被引量:5
  • 2唐锁勤,黄东生,王建文,冯晨,杨光.大剂量化疗造血干细胞移植治疗IV期神经母细胞瘤的长期疗效研究[J].中国当代儿科杂志,2006,8(2):93-96. 被引量:27
  • 3王焕民,张金哲,祝秀丹,秦红,李家驹.小儿恶性肿瘤治愈后远期复发[J].中国肿瘤临床,2007,34(13):761-763. 被引量:2
  • 4Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment [ J]. Prog Clin Bid Res, 1994, 385 : 363-369.
  • 5Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada[ J]. J Natl Cancer Inst, 2000, 92(3) : 205-216.
  • 6Matthay KK, Atkinson JB, Strata DO, Selch M, Reynolds CP, Seeger RC. Patterns of relapse after autologous purged bone mar- row transplantation for neuroblastoma: a Children's Cancer Group pilot study[J]. J Clin Oncol, 1993, 11 ( 11 ) : 2226-2233.
  • 7Garaventa A, Parodi S, De Bernardi B,Dau D, Manzitti C, Conte M, et al. Outcome of children with neuroblastoma after progres- sion or relapse. A retrospective study of the italian neuroblastoma registry[J]. Eur J Cancer, 2009, 45( 16): 2835-2842.
  • 8Lau L, Tai D, Weitzman S, Grant R, Baruchel S, Malkin D. Factors influencing survival in children with recurrent neuroblasto- ma[J]. J Pediatr Hematol Oncol, 2004, 26(4) : 227-232.
  • 9Miles SA, Sandier AD. CpG oligonucleotides for immunotherapeu- tic treatment of neuroblastoma[ J]. Adv Drug Deliv Rev, 2009, 61 (3) : 275-282.
  • 10Park JR, Digiusto DL, Slovak M, Wright C, Naranjo A, Wagner J, et al. Adoptive transfer of chimeric antigen receptor re-directed eytolytic T lymphocyte clones in patients with neuroblastoma[J]. Mol Ther, 2007, 15(4) : 825-833.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部